About Dr. Khan

Helping with depression

Doctor Arif Khan

Arif Khan, MD, is a Board Certified Psychiatrist and Adjunct Professor of Psychiatry at Duke University School of Medicine. He is the Medical Director and Principal Investigator at Northwest Clinical Research Center in Bellevue, Washington.  Dr. Khan has been conducting clinical trials in the greater Seattle area since 1984 and founded NWCRC in 1995.

Dr. Khan as conducted over 90 clinical trials studying depression.  His research has been instrumental in the FDA approval of medication such as venlafaxine, paroxetine, citalopram, duloxetine and vilazadone, just to name a few.  A sample of his published works on depression are linked below.

Vedantam S.  Against depression a sugar pill is hard to beat.  Washington Post: May 7th, 2002.

http://www.rawfoodinfo.com/articles/art_placebovsdrugs.html

Friedman RA.  Can the placebo treat depression? That depends.  New York Times: June 25th, 2002.

http://www.nytimes.com/2002/06/25/health/behavior-can-the-placebo-treat-depression-that-depends.html

Khan A, Khan S, Brown WA.  Are placebo controls necessary to test new antidepressants and anxiolytics?  International Journal of Neuropsychopharmacology 5: 193-197, 2002.

http://www.ncbi.nlm.nih.gov/pubmed?term=are%20placebo%20controls%20necessary%20to%20test%20new%20antidepressants%20and%20anxiolytics

Khan A, Kolts RL, Thase ME, Krishnan KR, Brown WA.  Research design features and patient characteristics associated with the outcome of antidepressant clinical trials.  American Journal of Psychiatry, 160(11): 2045-2049, 2004.

http://www.ncbi.nlm.nih.gov/pubmed/15514405

Khan A, Warner H, Brown, WA.  Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the FDA database.  Archives of General Psychiatry 57: 311-317, 2000. 

http://www.ncbi.nlm.nih.gov/pubmed?term=Symptom%20reduction%20and%20suicide%20risk%20in%20patients%20treated%20with%20placebo%20in%20antidepressant%20clinical%20trials%3A%20an%20analysis%20of%20the%20FDA%20database.%20Archives%20of%20General%20Psychiatry%2057%3A%20311-317%2C%202000.


Questionnaire:


Please let us know which of the following symptoms you may be experiencing.

 Feeling sad, hopeless, or discouraged Feeling restless or irritable Trouble with concentrating or memory Feeling tired or having little energy Difficulty performing daily activities Changes in appetite or weight Feelings of guilt or failure Disinterest in activities that normally give pleasure NONE

Do you have a history of any of the following?

 Seizure Disorder Stroke Head Injury Brain Tumor Cancer NONE

What is your Gender?
 Male Female

Are you over 18?
 Yes No

How did you hear about us?
 TV Radio Referral Flyer/Brochure Internet Search Web Advertisement Facebook Previous Patient

Please enter any questions or comments in the space below.

Name (First and Last):

Phone:

Email Address:

Are you a resident of Washington State?

Zip Code:

What is the best time to contact you?

Your information will not be shared with or sold to anyone without your permission or except as required by law. See our Privacy Statement for details.

 I agree to the Privacy Statement

© 1999-2011 Northwest Clinical Research Center